Thrombosis and inflammation: A question in need of an answer

Journal of Rheumatology

Volumn 32, Issue 3, 2005, Pages 397-399

  Bobba, Raja ^a   Landolt Marticorena, Carolina ^a   Fortin, Paul R ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; FIBRINOGEN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S;

ANTIGEN BINDING; ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBIN III DEFICIENCY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD ANALYSIS; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE MARKER; EDITORIAL; HUMAN; INFLAMMATION; NONHUMAN; PHLEBOTOMY; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK FACTOR; SEPSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ADULT; ANTIBODIES; CARDIOVASCULAR DISEASES; HUMANS; INFLAMMATION; LUPUS COAGULATION INHIBITOR; RISK FACTORS; VENOUS THROMBOSIS;

EID: 15044354700     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (21)

1. Lowe GDO. Venous and arterial thrombosis: epidemiology and risk factors at various ages. Maturitas 2004;47:259-63.
2. Rosendaal FR. Thrombosis in the young: Epidemiology and risk factors. A focus on venous thrombosis. Thromb Haemost 1997;78:1-6.
3. Davies MJ. Coronary disease - the pathophysiology of acute coronary syndromes. Heart 2000;83:361-6.
4. Shah PK. Pathophysiology of coronary thrombosis: Role of plaque rupture and plaque erosion. Prog Cardiovasc Dis 2002;44:357-68.
5. Rosendaal FR. Risk factors for venous thrombosis: Prevalence, risk, and interaction. Semin Hematol 1997;34:171-87.
6. Lee AY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003;349:146-53.
7. Esmon CT. Inflammation and thrombosis. J Thromb Haemost 2003;1:1343-8.
8. Matthay MA. Severe sepsis - A new treatment with both anticoagulant and antiinflammatory properties. N Engl J Med 2001;344:759-62.
9. Sailer T, Vormittag R, Pabinger I, et al. Inflammation in patients with lupus anticoagulant and implication for thrombosis. J Rheumatol 2005;32:462-8.
10. de Maat MPM, Bladbjerg EM, Drivsholm T, Borch-Johnsen K, Moller L, Jespersen J. Inflammation, thrombosis and atherosclerosis: results of the Glostrup study. J Thromb Haemost 2003;1:950-7.
11. Libby P, Simon DI. Inflammation and thrombosis - The clot thickens. Circulation 2001;103:1718-20.
12. Danesh J, Whincup P, Walker M, et al. Fibrin D-dimer and coronary heart disease - Prospective study and meta-analysis. Circulation 2001;103:2323-7.
13. Pai JK, Pischon T, Ma J, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004;351:2599-610.
14. Asanuma Y, Oeser A, Shintani AK, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2407-15.
15. Van Doornum S, McColl G, Wicks IP. Accelerated atherosclerosis - An extraarticular feature of rheumatoid arthritis? Arthritis Rheum 2002;46:862-73.
16. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004;351:2611-8.
17. Mazer SP, Rabbani LE. Evidence for C-reactive protein's role in (CRP) vascular disease: atherothrombosis, immuno-regulation and CRP. J Thromb Thrombolysis 2004;17:95-105.
18. Holers VM, Girardi G, Mo L, et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002;195:211-20.
19. Pierangeli SS, Vega-Ostertag M, Lui X, Holers M, Salmon J. An anti CR monoclonal antibody reverses antiphospholipid induced thrombosis [abstract]. Arthritis Rheum 2004;50 Suppl:S639-S40.
20. Girardi G, Berman J, Redecha P, et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 2003;112:1644-54.
21. Erkan D, Ortel TL, Lockshin MD. Warfarin in antiphospholipid syndrome - time to explore new horizons [editorial]. J Rheumatol 2005;32:208-12.